Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce that its subsidia ...

Generative Phosphoproteomics AP3 platform designed to enable streamlined, rational drug discovery, with proprietary, proteome ...

GEN spoke with Milad Dagher, PhD, CEO and co-founder of Nomic, about how the nELISA platform is transforming proteomics. GEN: What are key factors influencing the broader adoption of proteomics ...

Event to be held via webcast on March 25, 2025 at 4:00 p.m. ET To highlight differentiated drug discovery capabilities with ...

Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) will likely be posting its quarterly earnings results before the market ...

Among other topics, conversations at the meeting focused on new methods for measuring proteins as well as opportunities for automation and AI.

Acrivon Therapeutics, Inc.’s ACRV share price has dipped by 30.24%, which has investors questioning if this is right time to ...

The CellScape™ Precise Spatial Proteomics platform is a cutting-edge imaging solution for quantitative in situ spatial phenotyping. The CellScape platform enables highly multiplexed spatial proteomics ...

At the core of Acrivon’s innovative approach is its AP3 (Acrivon Predictive Precision Proteomics) platform. This technology has garnered attention for several reasons: It offers a unique method ...

Equities research analysts at HC Wainwright issued their FY2029 earnings estimates for Acrivon Therapeutics in a report issued on Wednesday, March 26th. HC Wainwright analyst E. Bodnar anticipates ...